SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Strategies & Market TrendsShort Squeeze Stocks


Previous 10 Next 10 
To: richardred who wrote (115)2/9/2006 12:41:40 PM
From: CapitalistHogg™
of 140
 
MATK up 18% on 8-K.

8-K: MARTEK BIOSCIENCES CORP
(EDGAR Online via COMTEX) --
-------------------------------------------------------------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): February 8, 2006

Martek Biosciences Corporation __________________________________________ (Exact name of registrant as specified in its charter)
Delaware 0-22354 52-1399362 _____________________ _____________ ______________ (State or other jurisdiction (Commission (I.R.S. Employer of incorporation) File Number) Identification No.) 6480 Dobbin Road, Columbia, Maryland 21045 _________________________________ ___________ (Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: 410-740-0081

Not Applicable ______________________________________________ Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

-------------------------------------------------------------------------------- Top of the Form
Item 7.01 Regulation FD Disclosure.
Martek’s revenues for the first quarter of fiscal 2006 are expected to be between $62 and $63 million compared to previously projected first quarter revenues of $58 to $59 million. These first quarter revenues represent growth in sales to core infant formula customers.
As previously disclosed, in February 2005, we entered into a DHA license and supply agreement with a major consumer packaged goods company. There are no minimum purchase requirements or financial commitments to us under the agreement and we have not recognized any material revenues under it to date. Since entering into the agreement, Martek has been working closely with the food company on product development efforts. Based on recent discussions with the food company and progress to date on these development efforts, Martek currently believes that, while subject to final product selection, food formulation and consumer testing, the food company now projects that the initial product launch of a food containing Martek DHA will take place in 2007.
In addition, Martek expects that another major consumer packaged goods company will be announcing and making the commercial introduction of a consumer food/ beverage product containing Martek’s DHA in the first quarter of calendar 2006.

-------------------------------------------------------------------------------- Top of the Form
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Martek Biosciences Corporation February 8, 2006 By: /s/ George P. Barker ---------------------------------- Name: George P. Barker Title: Senior Vice President, General Counsel and Secretary

Share KeepReplyMark as Last ReadRead Replies (1)


To: CapitalistHogg™ who wrote (127)2/9/2006 12:46:55 PM
From: richardred
of 140
 
This snip is key IMHO.

>the food company now projects that the initial product launch of a food containing Martek DHA will take place in 2007.
In addition, Martek expects that another major consumer packaged goods company will be announcing and making the commercial introduction of a consumer food/ beverage product containing Martek’s DHA in the first quarter of calendar 2006.

Share KeepReplyMark as Last Read


From: CapitalistHogg™2/13/2006 10:10:33 AM
of 140
 
IOTN Breaking out.

IOTN is also on the Reg SHO list and has been for the last 13 trading days.

PANL $ 12.49
Universal Display Corp. -0.03
Shares Short 2,745,796
Days To Cover (Short Ratio) 16.2
Short % of Float 9.91 %
Short % Increase/Decrease 2.43 %
Price % Change (52-wk) 62.11 %
% from 52-Week HIGH ( 14.22 ) -13.85 %
% from 200 DAY MA ( 11.93 ) 4.48 %
% from 50 Day MA ( 11.95 )4.32 %
% from 52-Week LOW ( 5.77 ) 53.80 %
Shares Short -Prior Mo 2,680,555
Todays Trading Volume 7,727
Avg. Daily Volume 169,914
Volume vs. Avg 4.55 %
Market Cap 361,277,727
Outstanding Shares 28,925,359
Float 27,700,000
% Held by Insiders 9.06 %
% Held by Institutions 27.00 %
EPS -0.51
PE Ratio
Sector: Technology
Industry: Computer Peripherals

Share KeepReplyMark as Last Read


To: CapitalistHogg™ who wrote (124)2/17/2006 10:45:04 AM
From: CapitalistHogg™
of 140
 
OFF TOPIC: I'm still bullish on MGPI longer term but waiting for more of a pullback before jumping back in. Ditto for PEIX.

Share KeepReplyMark as Last ReadRead Replies (2)


To: CapitalistHogg™ who wrote (130)2/23/2006 10:48:17 AM
From: CapitalistHogg™
of 140
 
Put in a limit order for MGPI @ 13.50. We are getting close to a six month trendline.

Share KeepReplyMark as Last Read


To: CapitalistHogg™ who wrote (130)2/24/2006 11:19:25 AM
From: CapitalistHogg™
of 140
 
I'm beginning to think PEIX is not ever going to pull back, chart looks bullish. I'm going to buy back in here soon...

Share KeepReplyMark as Last ReadRead Replies (1)


To: CapitalistHogg™ who wrote (85)2/27/2006 11:43:24 AM
From: CapitalistHogg™
of 140
 
HURC looks like a pretty good short here...

Share KeepReplyMark as Last Read


To: CapitalistHogg™ who wrote (132)2/27/2006 11:45:07 AM
From: CapitalistHogg™
of 140
 
I'm going to wait for earnings release for PEIX then buy in...

Hell I might even short this thing if it keeps running up before earnings. I think it is getting ahead of itself.

Share KeepReplyMark as Last Read


From: jmhollen6/15/2006 3:09:02 AM
of 140
 
LFWK has filed for a name and CUSIP change (..verified..), and the results should appear in a matter of bizdays. I'd suggest reading the LFWK Board soon, and consider doing some fortuitous last-minute collecting. Subject 56054

This one could be the 2006 Chevy Chase and Luckup Corporation 'Squeeze of the Century'..!!! Management owns 90%+ of the real shares and known/friendly insiders own a major chunk of the balance. What the MFMMMs have been slinging around to the public for a long time are DTCC 'See-thru Skivvies' Vapor Shares and the most righteous accounting for their NSS BS is going to be "..vel-l-l-l-l-l-l-y intellesting.." - IMHO..!!!

John :-)

.

Share KeepReplyMark as Last Read


From: Julius Wong9/21/2006 12:34:40 AM
of 140
 
Northfield Laboratories Inc. (NFLD)


Share KeepReplyMark as Last Read
Previous 10 Next 10